InsidersTradesSigma
Track the 에스바이오메딕스 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 에스바이오메딕스 has logged 4 insider filings. Market capitalisation: €244.6bn. The latest transaction was filed on 31 August 2026 (Sale). Among the most active insiders: KANG SAEIL. All data is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Cotizando en el mercado XKRX, 에스바이오메딕스 se especializa en el sector de la salud y farmacéutico. La empresa se enfoca en el desarrollo de soluciones médicas innovadoras.